Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Boelo J. Poppema"'
Autor:
Sophie A. Kurk, Petra H. M. Peeters, Bram Dorresteijn, Pim A. deJong, Marion Jourdan, Geert‐Jan M. Creemers, Frans L. G. Erdkamp, Felix E. deJongh, Peter A. M. Kint, Boelo J. Poppema, Sandra A. Radema, Lieke H. J. Simkens, Bea C. Tanis, Manuel L. R. Tjin‐A‐Ton, Ankie Van Der Velden, Cornelis J. A. Punt, Miriam Koopman, Anne M. May
Publikováno v:
Cancer Medicine, Vol 9, Iss 3, Pp 1033-1043 (2020)
Abstract Background Low skeletal muscle index (SMI) in metastatic colorectal cancer (mCRC) patients is associated with poor outcomes. The prognostic impact of SMI changes during consecutive palliative systemic treatments is unknown. Methods This is a
Externí odkaz:
https://doaj.org/article/434f0b15ebe24d0abcf39821804c932c
Autor:
Gabriela G.F. van der Schoot, Harm L. Ormel, Nico-Derk L. Westerink, Anne M. May, Sjoerd G. Elias, Yoran M. Hummel, Joop D. Lefrandt, Peter van der Meer, Joost P. van Melle, Boelo J. Poppema, Joyce M.A. Stel, Annette W.G. van der Velden, Aline H. Vrieling, Johan B. Wempe, Marcel G. ten Wolde, Marcel Nijland, Elisabeth G.E. de Vries, Jourik A. Gietema, Annemiek M.E. Walenkamp
Publikováno v:
JACC: CardioOncology. 4:491-503
Autor:
Miriam Koopman, Felix E de Jongh, Ankie M.T. van der Velden, Bram Dorresteijn, Sophie A Kurk, Pim A. de Jong, Geert-Jan Creemers, Petra H.M. Peeters, Frans L. G. Erdkamp, Marion Jourdan, Anne M May, Peter A M Kint, Boelo J Poppema, Lieke H.J. Simkens, Manuel L. R. Tjin-A-Ton, B.C. Tanis, Cornelis J. A. Punt, Sandra A Radema
Publikováno v:
Cancer Medicine, 9(3), 1033. John Wiley and Sons Ltd
Cancer Medicine
Cancer Medicine, Vol 9, Iss 3, Pp 1033-1043 (2020)
Cancer medicine, 9(3), 1033-1043. John Wiley and Sons Ltd
Cancer Medicine, 9, 1033-1043
Cancer Medicine, 9, 3, pp. 1033-1043
Cancer Medicine
Cancer Medicine, Vol 9, Iss 3, Pp 1033-1043 (2020)
Cancer medicine, 9(3), 1033-1043. John Wiley and Sons Ltd
Cancer Medicine, 9, 1033-1043
Cancer Medicine, 9, 3, pp. 1033-1043
Background Low skeletal muscle index (SMI) in metastatic colorectal cancer (mCRC) patients is associated with poor outcomes. The prognostic impact of SMI changes during consecutive palliative systemic treatments is unknown. Methods This is a retrospe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9423fcb999920710eadfa5693d7cdcb6
https://dspace.library.uu.nl/handle/1874/395432
https://dspace.library.uu.nl/handle/1874/395432